165 related articles for article (PubMed ID: 24671506)
1. Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity.
Brandt S; Krauel K; Gottschalk KE; Renné T; Helm CA; Greinacher A; Block S
Thromb Haemost; 2014 Jul; 112(1):53-64. PubMed ID: 24671506
[TBL] [Abstract][Full Text] [Related]
2. Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria.
Brandt S; Krauel K; Jaax M; Renné T; Helm CA; Hammerschmidt S; Delcea M; Greinacher A
Thromb Haemost; 2015 Nov; 114(6):1189-98. PubMed ID: 26225544
[TBL] [Abstract][Full Text] [Related]
3. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
4. Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4.
Kreimann M; Brandt S; Krauel K; Block S; Helm CA; Weitschies W; Greinacher A; Delcea M
Blood; 2014 Oct; 124(15):2442-9. PubMed ID: 25150299
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: frequency and pathogenesis.
Greinacher A
Pathophysiol Haemost Thromb; 2006; 35(1-2):37-45. PubMed ID: 16855345
[TBL] [Abstract][Full Text] [Related]
6. Distinct Binding Characteristics of Pathogenic Anti-Platelet Factor-4/Polyanion Antibodies to Antigens Coated on Different Substrates: A Perspective on Clinical Application.
Nguyen TH; Greinacher A
ACS Nano; 2018 Dec; 12(12):12030-12041. PubMed ID: 30540167
[TBL] [Abstract][Full Text] [Related]
7. Biophysical tools to assess the interaction of PF4 with polyanions.
Delcea M; Greinacher A
Thromb Haemost; 2016 Oct; 116(5):783-791. PubMed ID: 27658429
[TBL] [Abstract][Full Text] [Related]
8. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.
Visentin GP; Moghaddam M; Beery SE; McFarland JG; Aster RH
J Lab Clin Med; 2001 Jul; 138(1):22-31. PubMed ID: 11433225
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
11. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
13. New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cells.
Schulze A; Jensch I; Krauel K; Alahmad A; Müller HP; Greinacher A; Hundt M
Thromb Res; 2014 Jul; 134(1):174-81. PubMed ID: 24816371
[TBL] [Abstract][Full Text] [Related]
14. Atomic description of the immune complex involved in heparin-induced thrombocytopenia.
Cai Z; Yarovoi SV; Zhu Z; Rauova L; Hayes V; Lebedeva T; Liu Q; Poncz M; Arepally G; Cines DB; Greene MI
Nat Commun; 2015 Sep; 6():8277. PubMed ID: 26391892
[TBL] [Abstract][Full Text] [Related]
15. Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.
Jaax ME; Krauel K; Marschall T; Brandt S; Gansler J; Fürll B; Appel B; Fischer S; Block S; Helm CA; Müller S; Preissner KT; Greinacher A
Blood; 2013 Jul; 122(2):272-81. PubMed ID: 23673861
[TBL] [Abstract][Full Text] [Related]
16. Fondaparinux: does it cause HIT? Can it treat HIT?
Warkentin TE
Expert Rev Hematol; 2010 Oct; 3(5):567-81. PubMed ID: 21083474
[TBL] [Abstract][Full Text] [Related]
17. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
18. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia.
Krauel K; Pötschke C; Weber C; Kessler W; Fürll B; Ittermann T; Maier S; Hammerschmidt S; Bröker BM; Greinacher A
Blood; 2011 Jan; 117(4):1370-8. PubMed ID: 20959601
[TBL] [Abstract][Full Text] [Related]
19. Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes.
Krauel K; Weber C; Brandt S; Zähringer U; Mamat U; Greinacher A; Hammerschmidt S
Blood; 2012 Oct; 120(16):3345-52. PubMed ID: 22942185
[TBL] [Abstract][Full Text] [Related]
20. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity.
Nguyen TH; Medvedev N; Delcea M; Greinacher A
Nat Commun; 2017 May; 8():14945. PubMed ID: 28530237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]